TrialJournal of Crohn's & colitis2022

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.

Jeffrey S Hyams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.